Simulation of Disease Progression for Pharmaceutical Forecasting
Diseases that spread very rapidly such as acute myeloid leukemia (AML) are very hard to treat and can progress extremely quickly, often resulting in death. Simulating this disease progression and patient treatment could help to understand the behavior of it better, leading to improved outcomes for patients.